Cargando…
Nuclear Localization Sequence of FGF1 Is Not Required for Its Intracellular Anti-Apoptotic Activity in Differentiated Cells
Fibroblast growth factor 1 (FGF1) is considered primarily as a ligand for FGF surface receptors (FGFRs) through which it activates a number of cellular responses. In addition to its canonical mode of action, FGF1 can act intracellularly, before secretion or after internalization and translocation fr...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833943/ https://www.ncbi.nlm.nih.gov/pubmed/35159330 http://dx.doi.org/10.3390/cells11030522 |
_version_ | 1784649060388438016 |
---|---|
author | Lampart, Agata Sluzalska, Katarzyna Dominika Czyrek, Aleksandra Szerszen, Aleksandra Otlewski, Jacek Wiedlocha, Antoni Zakrzewska, Malgorzata |
author_facet | Lampart, Agata Sluzalska, Katarzyna Dominika Czyrek, Aleksandra Szerszen, Aleksandra Otlewski, Jacek Wiedlocha, Antoni Zakrzewska, Malgorzata |
author_sort | Lampart, Agata |
collection | PubMed |
description | Fibroblast growth factor 1 (FGF1) is considered primarily as a ligand for FGF surface receptors (FGFRs) through which it activates a number of cellular responses. In addition to its canonical mode of action, FGF1 can act intracellularly, before secretion or after internalization and translocation from the cell exterior. The role of FGF1 inside the cell is to provide additional protection against apoptosis and promote cell survival. The FGF1 protein contains a specific N-terminal nuclear localization sequence (NLS) that is essential for its efficient transport to the nucleus. Here, we investigated the role of this sequence in the anti-apoptotic response of FGF1. To this end, we produced recombinant FGF1 variants with mutated or deleted NLS and added them to apoptosis-induced cells in which FGFR1 was inactive, either as a result of chemical inhibition or kinase-dead mutation. After internalization, all FGF1 variants were able to protect the differentiated cells from serum starvation-induced apoptosis. To verify the results obtained for NLS mutants, we knocked down LRRC59, a protein that mediates the nuclear transport of FGF1. Upon LRRC59 silencing, we still observed a decrease in caspase 3/7 activity in cells treated exogenously with wild-type FGF1. In the next step, FGF1 variants with mutated or deleted NLS were expressed in U2OS cells, in which apoptosis was then induced by various factors (e.g., starvation, etoposide, staurosporine, anisomycin and actinomycin D). Experiments were performed in the presence of specific FGFR inhibitors to eliminate FGFR-induced signaling, potentially activated by FGF1 proteins released from damaged cells. Again, we found that the presence of NLS in FGF1 is not required for its anti-apoptotic activity. All NLS variants tested were able to act as wild type FGF1, increasing the cell viability and mitochondrial membrane potential and reducing the caspase 3/7 activity and PARP cleavage in cells undergoing apoptosis, both transiently and stably transfected. Our results indicate that the nuclear localization of FGF1 is not required for its intracellular anti-apoptotic activity in differentiated cells and suggest that the mechanism of the stress response differs according to the level of cell differentiation. |
format | Online Article Text |
id | pubmed-8833943 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88339432022-02-12 Nuclear Localization Sequence of FGF1 Is Not Required for Its Intracellular Anti-Apoptotic Activity in Differentiated Cells Lampart, Agata Sluzalska, Katarzyna Dominika Czyrek, Aleksandra Szerszen, Aleksandra Otlewski, Jacek Wiedlocha, Antoni Zakrzewska, Malgorzata Cells Article Fibroblast growth factor 1 (FGF1) is considered primarily as a ligand for FGF surface receptors (FGFRs) through which it activates a number of cellular responses. In addition to its canonical mode of action, FGF1 can act intracellularly, before secretion or after internalization and translocation from the cell exterior. The role of FGF1 inside the cell is to provide additional protection against apoptosis and promote cell survival. The FGF1 protein contains a specific N-terminal nuclear localization sequence (NLS) that is essential for its efficient transport to the nucleus. Here, we investigated the role of this sequence in the anti-apoptotic response of FGF1. To this end, we produced recombinant FGF1 variants with mutated or deleted NLS and added them to apoptosis-induced cells in which FGFR1 was inactive, either as a result of chemical inhibition or kinase-dead mutation. After internalization, all FGF1 variants were able to protect the differentiated cells from serum starvation-induced apoptosis. To verify the results obtained for NLS mutants, we knocked down LRRC59, a protein that mediates the nuclear transport of FGF1. Upon LRRC59 silencing, we still observed a decrease in caspase 3/7 activity in cells treated exogenously with wild-type FGF1. In the next step, FGF1 variants with mutated or deleted NLS were expressed in U2OS cells, in which apoptosis was then induced by various factors (e.g., starvation, etoposide, staurosporine, anisomycin and actinomycin D). Experiments were performed in the presence of specific FGFR inhibitors to eliminate FGFR-induced signaling, potentially activated by FGF1 proteins released from damaged cells. Again, we found that the presence of NLS in FGF1 is not required for its anti-apoptotic activity. All NLS variants tested were able to act as wild type FGF1, increasing the cell viability and mitochondrial membrane potential and reducing the caspase 3/7 activity and PARP cleavage in cells undergoing apoptosis, both transiently and stably transfected. Our results indicate that the nuclear localization of FGF1 is not required for its intracellular anti-apoptotic activity in differentiated cells and suggest that the mechanism of the stress response differs according to the level of cell differentiation. MDPI 2022-02-02 /pmc/articles/PMC8833943/ /pubmed/35159330 http://dx.doi.org/10.3390/cells11030522 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lampart, Agata Sluzalska, Katarzyna Dominika Czyrek, Aleksandra Szerszen, Aleksandra Otlewski, Jacek Wiedlocha, Antoni Zakrzewska, Malgorzata Nuclear Localization Sequence of FGF1 Is Not Required for Its Intracellular Anti-Apoptotic Activity in Differentiated Cells |
title | Nuclear Localization Sequence of FGF1 Is Not Required for Its Intracellular Anti-Apoptotic Activity in Differentiated Cells |
title_full | Nuclear Localization Sequence of FGF1 Is Not Required for Its Intracellular Anti-Apoptotic Activity in Differentiated Cells |
title_fullStr | Nuclear Localization Sequence of FGF1 Is Not Required for Its Intracellular Anti-Apoptotic Activity in Differentiated Cells |
title_full_unstemmed | Nuclear Localization Sequence of FGF1 Is Not Required for Its Intracellular Anti-Apoptotic Activity in Differentiated Cells |
title_short | Nuclear Localization Sequence of FGF1 Is Not Required for Its Intracellular Anti-Apoptotic Activity in Differentiated Cells |
title_sort | nuclear localization sequence of fgf1 is not required for its intracellular anti-apoptotic activity in differentiated cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833943/ https://www.ncbi.nlm.nih.gov/pubmed/35159330 http://dx.doi.org/10.3390/cells11030522 |
work_keys_str_mv | AT lampartagata nuclearlocalizationsequenceoffgf1isnotrequiredforitsintracellularantiapoptoticactivityindifferentiatedcells AT sluzalskakatarzynadominika nuclearlocalizationsequenceoffgf1isnotrequiredforitsintracellularantiapoptoticactivityindifferentiatedcells AT czyrekaleksandra nuclearlocalizationsequenceoffgf1isnotrequiredforitsintracellularantiapoptoticactivityindifferentiatedcells AT szerszenaleksandra nuclearlocalizationsequenceoffgf1isnotrequiredforitsintracellularantiapoptoticactivityindifferentiatedcells AT otlewskijacek nuclearlocalizationsequenceoffgf1isnotrequiredforitsintracellularantiapoptoticactivityindifferentiatedcells AT wiedlochaantoni nuclearlocalizationsequenceoffgf1isnotrequiredforitsintracellularantiapoptoticactivityindifferentiatedcells AT zakrzewskamalgorzata nuclearlocalizationsequenceoffgf1isnotrequiredforitsintracellularantiapoptoticactivityindifferentiatedcells |